Join leading researchers advancing nanomedicine, bioengineering, and molecular design through the power of protein cages.
The Protein Cage Network stemmed from a collaboration in Functional Design of Protein Cage for Sustainable Bionanomaterial project between members of the Asian Science and Technology Pioneering Institutes of Research and Education (ASPIRE). The website was supported through a joint research project by the Japan Society for the Promotion of Science (JSPS) and Nanyang Technological University (NTU), Singapore in collaboration with Tokyo Institute of Technology (TITech). It was officially launched at the Pacifichem in 2021 as part of the symposium Chemistry and Applications of Protein and Virus-based Nanotechnologies.
Protein cages are nanoscale particles formed by self-assembling protein subunits, with natural roles spanning storage (ferritin), protection (heat shock protei…Protein cages are nanoscale particles formed by self-assembling protein subunits, with natural roles spanning storage (ferritin), protection (heat shock proteins), catalysis, and genetic material transfer (viruses). Through nanotechnology, they have been repurposed for vaccine scaffolds, drug delivery, imaging, and molecular electronics, making them central to nanobiotechnology.
Apply to the Physics of Viruses
and Protein Cages exploring the intersection of molecular Design, dynamicsand biological Function. Apply for this conference by December 14th and register by December 21st, 2025.
Join us at the "Protein Cages as Next Generation Nanomaterials" Symposium (E8), co-chaired by Kanchan Chauhan & Rafael Vasquez Duhalt (UNAM) and Sierin Lim (NTU Singapore), at the 32nd IMRC (MRS/SMMater) in Cancun, Mexico — August 21–22, 2024.
NEW book on Protein Cage in Methods in Molecular Biology by Springer Nature co-edited by Takafumi Ueno, Sierin Lim, and Kelin Xia was published in 2023.
Apply to the Physics of Viruses
and Protein Cages exploring the intersection of molecular Design, dynamicsand biological Function. Apply for this conference by December 14th and register by December 21st, 2025.
Today we learned that Icosavax, a Seattle-based vaccine design company born from innovative research conducted here at the Institute for Protein Design, will be acquired by AstraZeneca in a deal worth up to $1.1 billion.
